The prevalence of cryptococcal antigenemia worldwide has ranged from 1.2 to 21.0%, depending on the geographic localization, age, clinical meningitis presence, and CD4+ cell count of the patients included in the study [15,16,17,18,19,20]. This evidence concerns the gene CD4 and meningitis.